nfcr.org
Dec 8, 2024, 06:53
The role of ADCs in the treatment of patients with Breast Cancer Brain Metastases – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X, about a recent paper by Stacey Pan et al. published in Sage Journals.
“Check out this recent review on the role of Antibody Drug Conjugates in the treatment of patients with Breast Cancer Brain Metastases.”
“Role of antibody-drug conjugates in the treatment of patients with breast cancer brain metastases”
Authors: Stacey Pan, Jayant Gadrey, Sarah Sammons, Nancy Lin, Sara Tolaney, Paolo Tarantino, Ilana Schlam.
More posts featuring Dana-Farber’s Breast Oncology Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32